Ani Pharmaceuticals (ANIP) Net Shares Issued and Repurchased (2012 - 2023)

Ani Pharmaceuticals has disclosed Net Shares Issued and Repurchased across 8 years of filings, most recently posting $28000.0 for Q1 2023.

• In Q1 2023, Net Shares Issued and Repurchased rose 3.7% year-over-year to $28000.0; the TTM figure through Mar 2023 stood at $28000.0 (up 3.7% YoY), while the FY2022 annual figure was $69000.0, down 58.93% from the prior year.
• Net Shares Issued and Repurchased came in at $28000.0 for Q1 2023 at Ani Pharmaceuticals, down from $69000.0 in the prior quarter.
• In the past five years, Net Shares Issued and Repurchased ranged from a high of $231000.0 in Q4 2020 to a low of $5000.0 in Q4 2019.
• Average Net Shares Issued and Repurchased over 5 years is $83777.8, with a median of $61000.0 recorded in 2021.
• The largest YoY upside for Net Shares Issued and Repurchased was 4520.0% in 2020 against a maximum downside of 94.9% in 2020.
• Over 5 years, Net Shares Issued and Repurchased stood at $5000.0 in 2019, then surged by 4520.0% to $231000.0 in 2020, then fell by 27.27% to $168000.0 in 2021, then plunged by 58.93% to $69000.0 in 2022, then sank by 59.42% to $28000.0 in 2023.
• Per Business Quant data, the three most recent Net Shares Issued and Repurchased figures were $28000.0 in Q1 2023, $69000.0 in Q4 2022, and $27000.0 in Q1 2022.